1. Lewnard JA, Liu VX, Jackson ML, Schmidt MA, Jewell BL,
Flores JP, et al. Incidence, clinical outcomes, and transmission
dynamics of severe coronavirus disease 2019 in California and
Washington: Prospective cohort study. BMJ 2020;369:m1923.
2. Moradzadeh R. The challenges and considerations of
community‑based preparedness at the onset of COVID‑19
outbreak in Iran, 2020. Epidemiol Infect 2020;148:e82.
3. Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al‑Jabir A,
et al. World Health Organization declares global emergency:
A review of the 2019 novel coronavirus (COVID‑19). Int J Surg
2020;76:71‑6.
4. Technical Reports of World Health Organization; 25 May, 2020.
Available from: https://www.who.int/docs/default‑source/
coronaviruse/situation‑reports/20200524‑covid‑19‑sitrep‑125.
pdf?sfvrsn=80e7d7f0_2. [Last accessed on 2020 Nov 29].
5. Rao C. Medical certification of cause of death for COVID‑19. Bull
World Health Organ 2020;98:298‑298A.
6. Moradzadeh R, Anoushirvani AA. Trend of gastric cancer
incidence in an area located in the Center of Iran: 2009‑2014.
J Gastrointest Cancer 2020;51:159‑64.
7. Health Emergencies Preparedness and Response, WHO Global.
Diagnostic Testing for SARS‑CoV‑2, Interim Guidance 11 September
2020. WHO REFERENCE NUMBER: WHO/2019‑nCoV/
laboratory/; 2020. p. 6. Available from: https://www.who.int/
publications/i/item/diagnostic‑testing‑for‑sars‑cov‑2. [Last
accessed on 2020 Sep 17].
8. McGahan CE, Linn K, Guno P, Johnson H, Coldman AJ, Spinelli JJ,
et al. Cancer in first nations people living in British Columbia,
Canada: An analysis of incidence and survival from 1993 to 2010.
Cancer Causes Control 2017;28:1105‑16.
9. Consonni D, Coviello E, Buzzoni C, Mensi C. A command to
calculate age‑standardized rates with efficient interval estimation.
Stata J 2012;12:688‑701.
10. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for
severity and mortality in adult COVID‑19 inpatients in Wuhan.
J Allergy Clin Immunol 2020;146:110‑118.
11. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course
and risk factors for mortality of adult inpatients with COVID‑19
in Wuhan, China: A retrospective cohort study. Lancet
2020;395:1054‑62.
12. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, et al.
Predictors of mortality for patients with COVID‑19 pneumonia
caused by SARS‑CoV‑2: A prospective cohort study. Europ Resp
J 2020;55:2000524.
13. Wu X, Nethery RC, Sabath BM, Braun D, Dominici F. Exposure
to air pollution and COVID‑19 mortality in the United States:
A nationwide cross‑sectional study. Sci Adv 2020;6:abd4049
14. Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association
between COVID‑19 mortality and health‑care resource
availability. Lancet Glob Health 2020;8:e480.
15. Jordan RE, Adab P, Cheng KK. Covid‑19: Risk factors for severe
disease and death. BMJ 2020;368:m1198.
16. Kazemi-Karyani A, Safari-Faramani R, Amini S, Ramezani-Doroh
V, Berenjian F, Dizaj MY, Hashempour R, Dizaj JY. World onehundred days after COVID-19 outbreak: Incidence, case fatality
rate, and trend. J Educ Health Promot 2020;9:1-10.
17. World Health Organization Team. Department of Communications,
Global Infectious Hazard Preparedness, WHO Global. Estimating
mortality from COVID‑19. WHO REFERENCE NUMBER:
WHO‑2019‑nCoV‑Sci_Brief‑Mortality‑2020. COVID‑19: Scientific Briefs;
1 August, 2020. Available from: https://www.who.int/publications/i/
item/WHO‑2019‑nCoV‑Sci‑Brief‑Mortality‑2020.1. [Last accessed on
2020 Sep 18].
18. Bhopal SS, BhopalR. Sex differential in COVID‑19 mortality varies
markedly by age. Lancet 2020;396:532‑3.
19. Kadel S, Kovats S. Sex hormones regulate innate immune cells
and promote sex differences in respiratory virus infection. Front
Immunol 2018;9:1653.
20. Michelozzi P, de’Donato F, Scortichini M, de Sario M, Noccioli F,
RossiP, et al. Mortality impacts of the coronavirus disease (COVID‑19)
outbreak by sex and age: Rapid mortality surveillance system, Italy,
1 February to 18 April 2020. Euro Surveill 2020;25:1‑5.
21. Mojtaba S, Maryam T, Yousef A, Sima A, Hadiseh H. Factors
associated with mortality in COVID‑19 patients: A systematic
review and meta‑analysis. Iran J Public Health 2020;49: 1211–1221.
22. Odegaard JI, Chawla A. Connecting type 1 and type 2 diabetes
through innate immunity. Cold Spring Harb Perspect Med
2012;2:a007724.
23. Guo L, Wei D, ZhangX, WuY, Li Q, Zhou M, et al. Clinical features
predicting mortality risk in patients with viral pneumonia: The
MuLBSTA score. Front Microbiol 2019;10:2752.
24. Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for
patients with diabetes in times of COVID‑19 epidemic. Diabetes
Metab Syndr 2020;14:211‑2.
25. Moradzadeh R, Mansournia MA, Baghfalaki T, Nadrian H,
Gustafson P, McCandless LC. The impact of maternal smoking
during pregnancy on childhood asthma: Adjusted for exposure
misclassification; results from the National Health and Nutrition
Examination Survey, 2011‑2012. Ann Epidemiol 2018;28:697‑703.
26. Moradzadeh R, Mansournia MA, Ghiasvand R, Baghfalaki T,
NadrianH, Holakouie‑NaieniK. Impact of age at menarche on breast
cancer: The assessment of recall Bias. Arch Iran Med 2019;22:65‑70.
27. Koolivand A, Amini S. The importance of PHC-based measures
in controlling COVID-19 outbreak: implications for global health
system. Ethics, Med. Public Health 2020;14: 1-3.
28. Nazari J, Amini S, Amiresmaili M. Lessons learned to control
COVID-19 to prevent a crisis: the case of Iran. Open Publ Health
J 2020;13:1-2.